Altimmune, Inc. (Nasdaq:ALT), a clinical stage immunotherapeutic biotechnology company, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Bill Enright, Chief Executive Officer, will ring the Opening Bell.
{iframe}http://www.nasdaq.com/press-release/altimmune-inc-nasdaq-alt-to-ring-the-nasdaq-stock-market-opening-bell-20170510-00997{/iframe}